Akums Drugs and Pharmaceuticals Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting
13-11-2025 | 04:45 pm
13-11-2025 | 04:45 pm
Akums approved consolidated financial results for the quarter (Profit ₹42.70 Cr) and half-year (Profit ₹107.38 Cr). It also announced a ₹200 Cr investment in its Zambian subsidiary for a new manufacturing facility and African expansion.
No comments yet. Be the first to comment!
All announcements from Akums Drugs and Pharmaceuticals Limited
